Administrative/Regulatory
Aug. 28, 2013
Drug to fight muscle-wasting diseases could be the next sports dope
There has been concern of possible abuse by athletes if new muscle-building drugs are approved by the FDA for the treatment of muscle-wasting diseases. By Leslie Krasny
The use of performance-enhancing drugs by athletes is widespread. Recent articles have speculated that the development of drugs to help build muscle, intended to help those with muscle-wasting diseases, may result in even more sports doping.
Myostatin, known as growth differentiation factor 8, was discovered in the 1990s. The protein acts during embryo development to limit the formation of muscle fibers, and also acts later in life to l...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In